SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-05-006490
Filing Date
2005-11-14
Accepted
2005-11-14 16:40:45
Documents
5
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. b57597ape10vq.htm 10-Q 411626
2 EX-31.1 SECTION 302 CERTIFICATION OF CEO b57597apexv31w1.htm EX-31.1 7940
3 EX-31.2 SECTION 302 CERTIFICATION OF CFO b57597apexv31w2.htm EX-31.2 7910
4 EX-32.1 SECTION 906 CERTIFICATION OF CEO b57597apexv32w1.htm EX-32.1 3146
5 EX-32.2 SECTION 906 CERTIFICATION OF CFO b57597apexv32w2.htm EX-32.2 3116
  Complete submission text file 0000950135-05-006490.txt   435200
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 051202181
SIC: 2834 Pharmaceutical Preparations